Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Southeast Asian J Trop Med Public Health ; 2004 Mar; 35(1): 172-4
Article in English | IMSEAR | ID: sea-33444

ABSTRACT

To study the efficacy of the combination of albendazole and prednisolone for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a 2-week course of prednisolone, 60 mg/day and albendazole, 15 mg/kg/ day. The primary observation parameter was the number of patients who still had headache after the 2-week course of treatment. Twenty-six patients were enrolled in the study. There were 3 (11.5%) patients who still had headache after the 2-week course of treatment and the median length of time until complete disappearance of headache was 4 days. Serious side effects were not detected. Treatment for 2 weeks with the combination regimen of albendazole and prednisolone is safe and effective for the treatment of eosinophilic meningitis.


Subject(s)
Administration, Oral , Adolescent , Adult , Albendazole/administration & dosage , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Therapy, Combination , Eosinophilia/diagnosis , Female , Follow-Up Studies , Humans , Male , Meningitis, Aseptic/diagnosis , Middle Aged , Prednisolone/administration & dosage , Prospective Studies , Risk Assessment , Severity of Illness Index , Thailand , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL